Next Article in Journal
Developing a Chromatographic Method for Quantifying Latanoprost and Related Substances in Glaucoma Treatments
Next Article in Special Issue
Structure–Activity Relationship Study of 3-Alkynyl-6-aryl-isothiazolo[4,3-b]pyridines as Dual Inhibitors of the Lipid Kinases PIKfyve and PIP4K2C
Previous Article in Journal
Development and Characterization of an Injectable Alginate/Chitosan Composite Hydrogel Reinforced with Cyclic-RGD Functionalized Graphene Oxide for Potential Tissue Regeneration Applications
 
 
Review

Article Versions Notes

Pharmaceuticals 2025, 18(5), 617; https://doi.org/10.3390/ph18050617
Action Date Notes Link
article xml file uploaded 24 April 2025 14:36 CEST Original file -
article xml uploaded. 24 April 2025 14:36 CEST Update https://www.mdpi.com/1424-8247/18/5/617/xml
article pdf uploaded. 24 April 2025 14:36 CEST Version of Record https://www.mdpi.com/1424-8247/18/5/617/pdf
article html file updated 24 April 2025 14:38 CEST Original file -
article html file updated 25 June 2025 01:39 CEST Update https://www.mdpi.com/1424-8247/18/5/617/html
Back to TopTop